KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Total Liabilities: 2009-2025

Historic Total Liabilities for Exact Sciences (EXAS) over the last 15 years, with Sep 2025 value amounting to $3.4 billion.

  • Exact Sciences' Total Liabilities fell 3.94% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 3.94%. This contributed to the annual value of $3.5 billion for FY2024, which is 6.01% up from last year.
  • Exact Sciences' Total Liabilities amounted to $3.4 billion in Q3 2025, which was up 2.12% from $3.3 billion recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Total Liabilities registered a high of $3.5 billion during Q3 2024, and its lowest value of $3.1 billion during Q1 2021.
  • Moreover, its 3-year median value for Total Liabilities was $3.3 billion (2023), whereas its average is $3.4 billion.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 61.78% in 2021, then fell by 4.39% in 2025.
  • Exact Sciences' Total Liabilities (Quarterly) stood at $3.3 billion in 2021, then dropped by 3.44% to $3.2 billion in 2022, then rose by 4.47% to $3.3 billion in 2023, then climbed by 6.01% to $3.5 billion in 2024, then fell by 3.94% to $3.4 billion in 2025.
  • Its Total Liabilities was $3.4 billion in Q3 2025, compared to $3.3 billion in Q2 2025 and $3.3 billion in Q1 2025.